Drug manufacturers have good relations with anti-doping officials

Today a lot of drug manufacturers are ready to collaborate with anti-doping officers in their fight against intake of banned preparations in sports. It sounds strange but it is the reality. In fact, if you look at the fate of EPO, you can understand why drug manufacturers agree to support efforts of anti-doping officials. EPO is really an efficacious remedy for treatment of anemia. A lot of individuals with anemia that have taken EPO have been treated. But what do you think while hearing about this preparation? Almost each individual associates this remedy only with doping in sports. This product has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated just with lying, disgrace, etc. Looking at this situation, drug manufacturers try to “defend” their medications from the similar fate. That’s why they collaborate with anti-doping officials.
Although certain drug manufacturers started to cooperate with anti-doping officers earlier, sometimes there were certain problems between them. Anti-doping agencies criticized certain pharmaceutical companies for their links to doping.
Nowadays relations between anti-doping agencies and drug manufacturers are better. Pharmaceutical companies share detailed information about new medicines with anti-doping officers. It is valuable information for development of detection tests for these medicines. While anti-doping agencies find out how medicines are manufactured, how they pass into body, how they work in the body, they can develop more efficient tests for these medications.
For example, the pharmaceutical company Roche that introduced the drug CERA helped anti-doping officers to introduce a detection test for it. Later other drug manufacturers followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during Olympics in London.
While relations between anti-doping officials and big drug manufacturers become stronger, smaller pharmaceutical companies begin to collaborate with anti-doping officers as well. While previously drug manufacturers haven’t wanted to discuss about their links to anti-doping officials publicly, now they don’t fear to announce about this condition.